• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Isomorphic Labs: Venture Capital Funding History

Isomorphic Labs

To add a bio or update company history, please click update information.

News from Isomorphic Labs

    Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidatesIsomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
    Isomorphic Labs
    11 May 2026

    Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates

    Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.

    Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmesIsomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes
    Isomorphic Labs
    31 Mar 2025

    Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes

    Isomorphic Labs applies advanced AI models to drug discovery, accelerating the design of new medicines across multiple therapeutic areas and partnering with global pharmaceutical companies.

Isomorphic Labs
  • Life Sciences
  • London, United Kingdom
  • £1.9bn
  • isomorphiclabs.com
  • Update Information

More venture news

  • Medcotec announces its £2.4m seed round from VCs to help pharma manufacturers transfer powders with single-use valves
    Medcotec
    15 Oct 2026

    Medcotec announces its £2.4m seed round from VCs to help pharma manufacturers transfer powders with single-use valves

    SeedLife Sciences
  • Silvia Bio raises a £3m seed round led by Northern Gritstone to improve complex biopharmaceutical manufacturing
    Silvia Bio
    15 Oct 2026

    Silvia Bio raises a £3m seed round led by Northern Gritstone to improve complex biopharmaceutical manufacturing

    SeedLife Sciences
  • Undecimal Bio lands a £14m seed round led by 4BIO Capital and IQ Capital to unlock targeted delivery of RNA drugs beyond the liver
    Undecimal Bio
    13 Oct 2026

    Undecimal Bio lands a £14m seed round led by 4BIO Capital and IQ Capital to unlock targeted delivery of RNA drugs beyond the liver

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn